Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teijin Pharma President To Become Group President

This article was originally published in PharmAsia News

Executive Summary

Teijin Pharma President Nario Oyagi is slated to be the new president of Teijin Group, and he is scheduled to be elected during the June 20 shareholders meeting. Oyagi joined the firm in 1971; he has since served as director for medical planning and general manager of medical business. Oyagi became president of Teijin Pharma in 2003. Discussing future visions for Teijin Pharma, Oyagi expects to expand worldwide into the home healthcare arena. Teijin Pharma has established an office in New York City, and it will actively promote business in America, Europe and Asia. (Click here for more-Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel